<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tpst-20260519.xsd" xlink:type="simple"/>
    <context id="duration_2026-05-19_to_2026-05-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
        </entity>
        <period>
            <startDate>2026-05-19</startDate>
            <endDate>2026-05-19</endDate>
        </period>
    </context>
    <context id="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-19</startDate>
            <endDate>2026-05-19</endDate>
        </period>
    </context>
    <context id="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001544227</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-19</startDate>
            <endDate>2026-05-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-256">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-05-19_to_2026-05-19"
      id="Hidden_dei_EntityCentralIndexKey">0001544227</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-283">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-284">2026-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-285">Tempest Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-286">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-287">001-35890</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-288">45-1472564</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-289">2000 Sierra Point Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-290">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-291">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-292">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-293">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-294">(415)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-295">798-8589</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-296">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-297">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-298">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-299">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-300">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-301">TPST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-302">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-303">Series A Junior Participating Preferred Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="duration_2026-05-19_to_2026-05-19_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-304">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-05-19_to_2026-05-19" id="ixv-305">false</dei:EntityEmergingGrowthCompany>
</xbrl>
